The influence of albumin on the efficacy of a Eu 2+ -containing complex capable of interacting with human serum albumin (HSA) was investigated at different field strengths (1.4, 3, 7, 9.4, and 11.7 T). Relaxometric measurements indicated that the presence of albumin at higher field strengths (>3 T) did not result in an increase in the relaxivity of the Eu 2+ complex, but a relaxation enhancement of 171% was observed at 1.4 T. Titration experiments using different percentages (2, 4.5, 6, 10, 15, and 25% w/v) of HSA and variable-temperature 17 O NMR measurements were performed to understand the effect of albumin on the molecular properties of the biphenyl-functionalized Eu 2+ complex that are relevant to magnetic resonance imaging.
Introduction
Magnetic resonance imaging (MRI) is a noninvasive imaging modality that can be used to study anatomical structures [1] , and the use of ultra-high field strength ( 7 T) magnets enables faster acquisition of MR images with increased spatial resolution [2] [3] [4] . However, common contrast agents such as low-molecular-weight Gd 3+ -containing complexes become less efficient at ultra-high field strengths relative to lower field strengths [5] . Unlike these Gd 3+ -based contrast agents, Eu 2+ -containing cryptates have higher relaxivity values at ultra-high field strengths (7 and 9.4 T) than at lower field strengths (1.4 and 3 T) [6, 7] .
We hypothesized that the relaxivity of Eu
2+
-containing cryptates could be increased by using strategies that improve the relaxivity of Gd 3+ -based agents. One of these strategies is the slowing of molecular-tumbling rate that can be influenced by covalent or noncovalent interactions with macromolecules including proteins [1, [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] . Human serum albumin (HSA), the most abundant protein in plasma with concentration of ~670 μM or 4.5% (w/v) [16] , noncovalently binds to some contrast agents that contain lipophilic moieties [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . McMurry and coworkers reported an increase in relaxivity of over 200% as a result of the noncovalent interaction of albumin with a Gd 3+ -containing complex functionalized with biphenyl [25] .
Because of the work with Gd 3+ and the ability to influence the properties of Eu 2+ with functionalized cryptands [28] , we hypothesized that a cryptand with a biphenyl group would produce a Eu 2+ complex that interacts with albumin to result in an increase in relaxivity.
To test our hypothesis, we synthesized biphenyl-modified Eu
-containing cryptate 1 ( Fig. 1) , and measured the relaxivity of cryptate 1 in the presence and absence of HSA at different field strengths (1.4, 3, 7, 9.4, and 11.7 T). We compared the resulting relaxivity values 3 to estimates calculated using the Solomon-Bloembergen-Morgan equations [29] . We also illustrated the effect of albumin on the contrast-enhancing ability of 1 using phantom images acquired at 7 T. Finally, we performed variable-temperature 17 O NMR experiments that probed the molecular basis of the relaxivity values of complex 1 in the presence and absence of HSA.
Fig. 1. Structure of biphenyl-functionalized Eu

2+
-containing complex 1.
Material and methods
Materials
Commercially available chemicals were of reagent-grade purity or better and were used without further purification unless otherwise noted. Biphenyl-functionalized cryptand and cryptate 1 were prepared following a published procedure [6] .
Concentrations
Samples for inductively coupled plasma mass spectrometry (ICP-MS) were diluted using aqueous nitric acid (2% v/v). Standard solutions were prepared by serial dilution of a Eu standard (High-Purity Standards). ICP-MS measurements were conducted on a PE Sciex Elan 9000 ICP-MS instrument with a cross-flow nebulizer and Scott-type spray chamber. 
Preparation of HSA samples
T 1 and relaxivity measurements
Longitudinal relaxation times, T 1 , were measured using standard recovery methods with a were used in the SWI experiments to allow for the determination of longitudinal relaxation time, [30] . MR images were processed using SPIN software (SVN Revision 1751 
Results and discussion
Biphenyl-functionalized cryptate 1 was designed based on the structure of Gd 3+ -based contrast agents that interact with HSA. These Gd
3+
-containing albumin-binding contrast agents contain lipophilic aryl groups such as the biphenyl moiety that enable them to interact with HSA [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . Therefore, we expected that the lipophilic biphenyl moiety in cryptate 1 would enable investigation of the effect of albumin binding on the relaxivity of Eu 2+ at different field strengths.
The relaxivity, r 1 , of 1 in PBS in the presence and absence of HSA was measured at multiple field strengths, and because not all of the magnets were capable of variable-temperature measurements, we separated data into Fig. 2a and Fig. 2b so that measurements obtained at each 6 temperature can be compared. In the absence of HSA, the r 1 of 1 at 20 °C is higher at 7 and 9.4 T than at 3 T suggesting that this complex is more efficient at ultra-high field strengths than at lower field strengths (Fig. 2a) . However, we found that the r 1 values at 3 and 11.7 T were not different (Student t test). Moreover, the relaxivity of 1 as a function of field strength is similar to other Eu
2+
-containing cryptates in the same conditions [7] . In the presence of HSA (4.5% w/v), the relaxivity of 1 decreased by 25-40% at field strengths of 3, 7, 9.4, and 11.7 T (Fig. 2a) .
However, at 37 °C and 1.4 T, the r 1 of 1 in the presence of albumin was 171% higher than in the absence of HSA (Fig. 2b ). An increase of 218% in relaxivity (measured at 37 °C and 0.47 T -containing cryptate at multiple field strengths using the SolomonBloembergen-Morgan equations ( Fig. 2b and Supplementary material).
To better understand the effect of albumin on the relaxivity of 1, titration experiments were performed using different percentages (2, 4.5, 6, 10, 15, and 25% w/v) of HSA while keeping the concentration (1 mM) of cryptate 1 constant. In preparation of 1, two equivalents of the biphenyl cryptand were used for each equivalent of Eu 2+ to facilitate metalation of the biphenyl cryptand; therefore, the samples 2, 4.5, 6, and 10% HSA have an excess of biphenyl relative to HSA (HSA/1 < 1 except 10% HSA sample) and samples with 15 and 25% HSA have 7 a subcess of biphenyl relative to HSA (HSA/1 > 1). The MR images (Fig. 3a) of 1 with HSA/1 ratios less than one have higher signal intensities as compared to the images of samples with HSA/1 ratios greater than 1. To quantify this observation, the proton longitudinal relaxation rate, 1/T 1 , of the sample with the lowest HSA/1 ratio is 103% higher than the sample with the highest HSA/1 ratio and 47% higher than the other sample (15% HSA) that has an excess of HSA relative to biphenyl (Fig. 3b) . The difference in signal intensity and 1/T 1 values among the samples indicate that the presence of albumin affects the relaxivity of complex 1 and does not translate to a higher signal intensity and higher efficacy of 1 at ultra-high fields. These observations support the relaxivity measurements described in Figure 2 . error of the mean of 3-9 independently prepared samples.
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To explain the observations of relaxivity, we performed variable-temperature 17 O NMR measurements using a sample of 1 in PBS and 1 in PBS with 25% HSA. We chose 25% HSA because the majority of 1 was expected to be bound to albumin at this percentage [25] , and the 17 O NMR data obtained from this sample would be representative of the molecular properties of cryptate 1 that is bound to HSA. The molecular properties that influence relaxivity that were studied using variable-temperature 17 O NMR spectroscopy were the residence lifetime of bound water molecules, m 298 ; the water-exchange rate, k ex 298 = 1/ m 298 ; and the number of inner-sphere water molecules, q (Table 1) . While the residence lifetime of bound water of cryptate 1 was not different (Student t test) in the presence and absence of albumin, the number of inner-sphere water molecules was reduced from two to one upon addition of albumin indicating that the observed decrease in relaxivity for cryptate 1 in the presence of albumin at 3, 7, 9.4, and 11.7 T is likely caused by the displacement of inner-sphere water molecules from the Eu 2+ complex.
Moreover, the residence lifetime of bound water was not different in the presence or absence of albumin suggesting that protein side chains do not hinder the remaining bound water molecule from exchanging with the bulk solvent. With the water-exchange rate and the number of innersphere water molecules of 1 in the presence of HSA remaining constant at different field strengths, the relaxivity enhancement observed at 1.4 T likely can be attributed to the enhanced contribution of rotational correlation rate at this field strength. 
Conclusions
The relaxation profile of Eu
2+
-containing cryptate 1 in the absence of albumin shows that cryptate 1 is more efficient at higher field strengths (7 and 9.4 T) than at lower field strengths The calculated relaxivity decreases from 1.4 T to 11.7 T (Table 1) . Assumptions made in the calculations are that the electronic parameters, v and 2 , do not change with magnetic field and that the values of v and 2 that were measured at 0.34 T are valid at higher field strengths. It was also assumed that the R for the biphenyl-modified cryptate in the presence of HSA is the same as that of MS-325 in the presence of HSA at 37 C.
